Details for: VPS13C
Gene ID: 54832
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: VPS13C
Ensembl ID: ENSG00000129003
Description: vacuolar protein sorting 13 homolog C
Selected Context(s): Overall
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 67.96rCSI 84.54%PRS 7.89
-
CSI 58.47rCSI 75.38%PRS 8.9
-
CSI 55.1rCSI 92.48%PRS 8.49
-
CSI 55.03rCSI 65.73%PRS 8.29
-
CSI 41.66rCSI 67%PRS 9.27
-
CSI 36.21rCSI 88%PRS 8.27
-
CSI 35.34rCSI 64.21%PRS 11.74
-
CSI 34.12rCSI 75.37%PRS 10.33
-
CSI 31.35rCSI 55.37%PRS 8.42
-
CSI 30.53rCSI 95.49%PRS 9.71
-
CSI 27.76rCSI 86.75%PRS 9.05
-
CSI 24.65rCSI 88.69%PRS 7.91
-
CSI 23.31rCSI 88.11%PRS 8.67
-
CSI 20.9rCSI 30.58%PRS 15.18
-
CSI 19.24rCSI 27.28%PRS 13.42
-
CSI 17.79rCSI 33.59%PRS 17.9
-
CSI 17.59rCSI 46.84%PRS 11.52
-
CSI 16.89rCSI 36.63%PRS 8.4
-
CSI 15.7rCSI 40.59%PRS 13.42
-
CSI 15.68rCSI 12.08%PRS 13.1
-
CSI 15.51rCSI 91.33%PRS 8.9
-
CSI 15.41rCSI 51.07%PRS 13.66
-
CSI 13.99rCSI 16.17%PRS 10.51
-
CSI 13.91rCSI 22.38%PRS 11.06
-
CSI 13.53rCSI 53.59%PRS 19.98
-
CSI 13.07rCSI 20.79%PRS 12.25
-
CSI 12.86rCSI 94.53%PRS 7.65
-
CSI 12.85rCSI 18.17%PRS 19.92
-
CSI 12.15rCSI 16.63%PRS 14.47
-
CSI 12.09rCSI 31.51%PRS 13.23
-
CSI 11.38rCSI 9.9%PRS 17.79
-
CSI 11.27rCSI 28.59%PRS 10.95
-
CSI 10.39rCSI 26.99%PRS 18.93
-
CSI 10.2rCSI 50.7%PRS 15.37
-
CSI 10.02rCSI 22.04%PRS 8.7
-
CSI 9.02rCSI 9.45%PRS 15.37
-
CSI 8.82rCSI 19.42%PRS 21.96
-
CSI 8.4rCSI 28.79%PRS 12.59
-
CSI 8.33rCSI 24.72%PRS 20.74
-
CSI 8.23rCSI 66.95%PRS 14.82
-
CSI 7.85rCSI 31.61%PRS 33.59
-
CSI 7.66rCSI 5.74%PRS 23.27
-
CSI 7.66rCSI 33.65%PRS 11.15
-
CSI 7.48rCSI 16.39%PRS 19.16
-
CSI 7.21rCSI 6.34%PRS 10.41
-
CSI 6.87rCSI 16.01%PRS 29.6
-
CSI 6.37rCSI 20.95%PRS 7.8
-
CSI 6.21rCSI 88.07%PRS 10.3
-
CSI 6.05rCSI 9.23%PRS 13.39
-
CSI 5.34rCSI 28.1%PRS 16.36
-
CSI 5.18rCSI 11.61%PRS 8.85
-
CSI 5.14rCSI 44.25%PRS 5.32
-
CSI 5.13rCSI 8.31%PRS 14.57
-
CSI 5.08rCSI 15.02%PRS 10.5
-
CSI 5rCSI 8.91%PRS 24.3
-
CSI 4.94rCSI 29.92%PRS 31.9
-
CSI 4.72rCSI 8.48%PRS 12.01
-
CSI 4.61rCSI 18.34%PRS 25.22
-
CSI 4.47rCSI 91.02%PRS 11.04
-
CSI 4.43rCSI 13.66%PRS 21.74
-
CSI 4.37rCSI 3.68%PRS 23.14
-
CSI 4.31rCSI 4.85%PRS 23.07
-
CSI 4.01rCSI 9.35%PRS 33.86
-
CSI 3.84rCSI 3.29%PRS 24.73
-
CSI 3.81rCSI 9.11%PRS 8.22
-
CSI 3.72rCSI 25.31%PRS 14.21
-
CSI 3.68rCSI 88.16%PRS 6.7
-
CSI 3.64rCSI 87.87%PRS 7.64
-
CSI 3.63rCSI 5.48%PRS 14.25
-
CSI 3.45rCSI 4.59%PRS 15.71
-
CSI 3.37rCSI 8.33%PRS 13.27
-
CSI 3.29rCSI 6.83%PRS 14.35
-
CSI 3.27rCSI 2.29%PRS 15.12
-
CSI 3.24rCSI 3.2%PRS 52.13
-
CSI 3.13rCSI 3.89%PRS 15.18
-
CSI 3.05rCSI 2.47%PRS 23.04
-
CSI 3.05rCSI 6.27%PRS 14.43
-
CSI 3.03rCSI 17.05%PRS 44.49
-
CSI 3.02rCSI 17.85%PRS 14.86
-
CSI 2.99rCSI 2.24%PRS 40.55
-
CSI 2.98rCSI 2.39%PRS 25.97
-
CSI 2.97rCSI 7.06%PRS 21.58
-
CSI 2.89rCSI 2.29%PRS 9.89
-
CSI 2.89rCSI 67.24%PRS 26.16
-
CSI 2.87rCSI 4.97%PRS 10.94
-
CSI 2.84rCSI 5.76%PRS 6.4
-
CSI 2.8rCSI 7.29%PRS 14.11
-
CSI 2.78rCSI 2.74%PRS 15.65
-
CSI 2.78rCSI 9.11%PRS 39.21
-
CSI 2.78rCSI 3.72%PRS 54.64
-
CSI 2.78rCSI 2.77%PRS 12.28
-
CSI 2.77rCSI 7.4%PRS 12.04
-
CSI 2.72rCSI 10.18%PRS 12.22
-
CSI 2.7rCSI 3.47%PRS 14.25
-
CSI 2.55rCSI 4.86%PRS 22.89
-
CSI 2.55rCSI 6.12%PRS 21.51
-
CSI 2.54rCSI 13.91%PRS 23.97
-
CSI 2.54rCSI 2.98%PRS 19.15
-
CSI 2.53rCSI 3.22%PRS 16.72
-
CSI 2.49rCSI 3.61%PRS 21.25
-
CSI -5.4rCSI -5.0%PRS 26.1%
-
CSI -3.6rCSI -4.8%PRS 12.8%
-
CSI -2.7rCSI -16.9%PRS 11.3%
-
CSI -2.5rCSI -3.3%PRS 14.0%
-
CSI -1.8rCSI -2.8%PRS 25.2%
-
CSI -1.4rCSI -12.7%PRS 6.8%
-
CSI -1.0rCSI -1.2%PRS 18.1%
-
CSI -0.4rCSI -3.8%PRS 14.5%
-
CSI -0.2rCSI -0.4%PRS 17.2%
-
CSI -0.1rCSI -0.1%PRS 12.6%
-
CSI 0.0rCSI 0.2%PRS 25.9%
-
CSI 0.1rCSI 0.4%PRS 20.9%
-
CSI 0.1rCSI 0.3%PRS 23.5%
-
CSI 0.1rCSI 1.4%PRS 43.5%
-
CSI 0.1rCSI 0.6%PRS 26.2%
-
CSI 0.1rCSI 0.6%PRS 28.0%
-
CSI 0.1rCSI 0.6%PRS 21.6%
-
CSI 0.1rCSI 0.4%PRS 23.7%
-
CSI 0.1rCSI 0.7%PRS 22.1%
-
CSI 0.1rCSI 0.2%PRS 18.5%
-
CSI 0.1rCSI 0.2%PRS 13.5%
-
CSI 0.1rCSI 0.1%PRS 15.0%
-
CSI 0.1rCSI 0.5%PRS 23.5%
-
CSI 0.1rCSI 1.1%PRS 13.0%
-
CSI 0.2rCSI 0.3%PRS 19.3%
-
CSI 0.2rCSI 0.9%PRS 48.1%
-
CSI 0.2rCSI 1.4%PRS 14.4%
-
CSI 0.2rCSI 1.3%PRS 38.6%
-
CSI 0.2rCSI 0.3%PRS 14.4%
-
CSI 0.2rCSI 2.6%PRS 49.8%
-
CSI 0.2rCSI 0.9%PRS 27.2%
-
CSI 0.2rCSI 0.6%PRS 23.4%
-
CSI 0.2rCSI 1.0%PRS 6.5%
-
CSI 0.2rCSI 0.4%PRS 38.8%
-
CSI 0.2rCSI 1.0%PRS 39.1%
-
CSI 0.2rCSI 1.7%PRS 16.0%
-
CSI 0.2rCSI 0.2%PRS 17.3%
-
CSI 0.2rCSI 2.0%PRS 14.3%
-
CSI 0.3rCSI 1.8%PRS 42.8%
-
CSI 0.3rCSI 0.3%PRS 16.9%
-
CSI 0.3rCSI 0.2%PRS 16.1%
-
CSI 0.3rCSI 0.5%PRS 19.0%
-
CSI 0.3rCSI 0.8%PRS 22.2%
-
CSI 0.3rCSI 1.3%PRS 37.5%
-
CSI 0.3rCSI 1.8%PRS 33.0%
-
CSI 0.3rCSI 0.7%PRS 22.8%
-
CSI 0.3rCSI 0.4%PRS 18.7%
-
CSI 0.3rCSI 2.2%PRS 13.9%
-
CSI 0.3rCSI 4.9%PRS 35.2%
-
CSI 0.3rCSI 1.8%PRS 35.1%
-
CSI 0.3rCSI 1.0%PRS 25.4%
-
CSI 0.4rCSI 2.4%PRS 36.7%
-
CSI 0.4rCSI 0.8%PRS 32.8%
-
CSI 0.4rCSI 1.8%PRS 33.6%
-
CSI 0.4rCSI 1.1%PRS 54.1%
-
CSI 0.4rCSI 0.5%PRS 18.4%
-
CSI 0.4rCSI 1.4%PRS 17.4%
-
CSI 0.4rCSI 2.2%PRS 25.5%
-
CSI 0.4rCSI 4.6%PRS 19.7%
-
CSI 0.4rCSI 1.9%PRS 55.0%
-
CSI 0.4rCSI 2.3%PRS 25.2%
-
CSI 0.4rCSI 1.1%PRS 25.9%
-
CSI 0.5rCSI 1.5%PRS 20.8%
-
CSI 0.5rCSI 0.8%PRS 37.2%
-
CSI 0.5rCSI 1.6%PRS 50.5%
-
CSI 0.5rCSI 3.8%PRS 54.3%
-
CSI 0.5rCSI 1.2%PRS 19.8%
-
CSI 0.5rCSI 1.5%PRS 16.3%
-
CSI 0.5rCSI 2.4%PRS 29.3%
-
CSI 0.5rCSI 0.8%PRS 18.9%
-
CSI 0.5rCSI 0.4%PRS 25.4%
-
CSI 0.5rCSI 0.5%PRS 29.6%
-
CSI 0.5rCSI 1.5%PRS 23.7%
-
CSI 0.6rCSI 0.7%PRS 20.2%
-
CSI 0.6rCSI 0.6%PRS 22.6%
-
CSI 0.6rCSI 1.2%PRS 29.1%
-
CSI 0.6rCSI 0.8%PRS 16.6%
-
CSI 0.6rCSI 1.9%PRS 15.3%
-
CSI 0.6rCSI 3.2%PRS 28.0%
-
CSI 0.6rCSI 0.5%PRS 14.3%
-
CSI 0.6rCSI 0.9%PRS 16.5%
-
CSI 0.6rCSI 0.9%PRS 34.2%
-
CSI 0.6rCSI 0.6%PRS 12.8%
-
CSI 0.6rCSI 0.6%PRS 16.5%
-
CSI 0.6rCSI 2.4%PRS 29.4%
-
CSI 0.6rCSI 0.8%PRS 17.0%
-
CSI 0.6rCSI 1.8%PRS 20.3%
-
CSI 0.6rCSI 0.7%PRS 13.2%
-
CSI 0.7rCSI 0.9%PRS 27.4%
-
CSI 0.7rCSI 7.1%PRS 27.5%
-
CSI 0.7rCSI 2.6%PRS 31.0%
-
CSI 0.7rCSI 1.0%PRS 19.7%
-
CSI 0.7rCSI 1.4%PRS 21.7%
-
CSI 0.7rCSI 1.1%PRS 18.2%
-
CSI 0.7rCSI 1.2%PRS 16.8%
-
CSI 0.7rCSI 1.0%PRS 16.7%
-
CSI 0.7rCSI 4.1%PRS 6.5%
-
CSI 0.7rCSI 1.3%PRS 22.0%
-
CSI 0.7rCSI 3.5%PRS 14.3%
-
CSI 0.7rCSI 4.8%PRS 21.5%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 188485766
Symbol: VP13C_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 15498460
Title: Analysis of the human VPS13 gene family.
PubMed ID: 15498460
PubMed ID: 10718198
Title: Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.
PubMed ID: 10718198
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 19413330
Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
PubMed ID: 19413330
DOI: 10.1021/ac9004309
PubMed ID: 19690332
Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
PubMed ID: 19690332
PubMed ID: 19608861
Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.
PubMed ID: 19608861
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 22814378
Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.
PubMed ID: 22814378
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 24129315
Title: Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.
PubMed ID: 24129315
PubMed ID: 26942284
Title: Loss of mitochondrial morphology, transmembrane potential, and respiration function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/Parkin-dependent mitophagy.
PubMed ID: 26942284
PubMed ID: 25787250
Title: Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas.
PubMed ID: 25787250
PubMed ID: 30093493
Title: VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites.
PubMed ID: 30093493
Sequence Information:
- Length: 3753
- Mass: 422390
- Checksum: 8B51A6778A89F639
- Sequence:
MVLESVVADL LNRFLGDYVE NLNKSQLKLG IWGGNVALDN LQIKENALSE LDVPFKVKAG QIDKLTLKIP WKNLYGEAVV ATLEGLYLLV VPGASIKYDA VKEEKSLQDV KQKELSRIEE ALQKAAEKGT HSGEFIYGLE NFVYKDIKPG RKRKKHKKHF KKPFKGLDRS KDKPKEAKKD TFVEKLATQV IKNVQVKITD IHIKYEDDVT DPKRPLSFGV TLGELSLLTA NEHWTPCILN EADKIIYKLI RLDSLSAYWN VNCSMSYQRS REQILDQLKN EILTSGNIPP NYQYIFQPIS ASAKLYMNPY AESELKTPKL DCNIEIQNIA IELTKPQYLS MIDLLESVDY MVRNAPYRKY KPYLPLHTNG RRWWKYAIDS VLEVHIRRYT QMWSWSNIKK HRQLLKSYKI AYKNKLTQSK VSEEIQKEIQ DLEKTLDVFN IILARQQAQV EVIRSGQKLR KKSADTGEKR GGWFSGLWGK KESKKKDEES LIPETIDDLM TPEEKDKLFT AIGYSESTHN LTLPKQYVAH IMTLKLVSTS VTIRENKNIP EILKIQIIGL GTQVSQRPGA QALKVEAKLE HWYITGLRQQ DIVPSLVASI GDTTSSLLKI KFETNPEDSP ADQTLIVQSQ PVEVIYDAKT VNAVVEFFQS NKGLDLEQIT SATLMKLEEI KERTATGLTH IIETRKVLDL RINLKPSYLV VPQTGFHHEK SDLLILDFGT FQLNSKDQGL QKTTNSSLEE IMDKAYDKFD VEIKNVQLLF ARAEETWKKC RFQHPSTMHI LQPMDIHVEL AKAMVEKDIR MARFKVSGGL PLMHVRISDQ KMKDVLYLMN SIPLPQKSSA QSPERQVSSI PIISGGTKGL LGTSLLLDTV ESESDDEYFD AEDGEPQTCK SMKGSELKKA AEVPNEELIN LLLKFEIKEV ILEFTKQQKE EDTILVFNVT QLGTEATMRT FDLTVVSYLK KISLDYHEIE GSKRKPLHLI SSSDKPGLDL LKVEYIKADK NGPSFQTAFG KTEQTVKVAF SSLNLLLQTQ ALVASINYLT TIIPSDDQSI SVAKEVQIST EKQQKNSTLP KAIVSSRDSD IIDFRLFAKL NAFCVIVCNE KNNIAEIKIQ GLDSSLSLQS RKQSLFARLE NIIVTDVDPK TVHKKAVSIM GNEVFRFNLD LYPDATEGDL YTDMSKVDGV LSLNVGCIQI VYLHKFLMSL LNFLNNFQTA KESLSAATAQ AAERAATSVK DLAQRSFRVS INIDLKAPVI VIPQSSISTN AVVVDLGLIR VHNQFSLVSD EDYLNPPVID RMDVQLTKLT LYRTVIQPGI YHPDIQLLHP INLEFLVNRN LAASWYHKVP VVEIKGHLDS MNVSLNQEDL NLLFRILTEN LCEGTEDLDK VKPRVQETGE IKEPLEISIS QDVHDSKNTL TTGVEEIRSV DIINMLLNFE IKEVVVTLMK KSEKKGRPLH ELNVLQLGME AKVKTYDMTA KAYLKKISMQ CFDFTDSKGE PLHIINSSNV TDEPLLKMLL TKADSDGPEF KTIHDSTKQR LKVSFASLDL VLHLEALLSF MDFLSSAAPF SEPSSSEKES ELKPLVGESR SIAVKAVSSN ISQKDVFDLK ITAELNAFNV FVCDQKCNIA DIKIHGMDAS ISVKPKQTDV FARLKDIIVM NVDLQSIHKK AVSILGDEVF RFQLTLYPDA TEGEAYADMS KVDGKLSFKV GCIQIVYVHK FFMSLLNFLN NFQTAKEALS TATVQAAERA ASSMKDLAQK SFRLLMDINL KAPVIIIPQS SVSPNAVIAD LGLIRVENKF SLVPMEHYSL PPVIDKMNIE LTQLKLSRTI LQASLPQNDI EILKPVNMLL SIQRNLAAAW YVQIPGMEIK GKLKPMQVAL SEDDLTVLMK ILLENLGEAS SQPSPTQSVQ ETVRVRKVDV SSVPDHLKEQ EDWTDSKLSM NQIVSLQFDF HFESLSIILY NNDINQESGV AFHNDSFQLG ELRLHLMASS GKMFKDGSMN VSVKLKTCTL DDLREGIERA TSRMIDRKND QDNNSSMIDI SYKQDKNGSQ IDAVLDKLYV CASVEFLMTV ADFFIKAVPQ SPENVAKETQ ILPRQTATGK VKIEKDDSVR PNMTLKAMIT DPEVVFVASL TKADAPALTA SFQCNLSLST SKLEQMMEAS VRDLKVLACP FLREKRGKNI TTVLQPCSLF MEKCTWASGK QNINIMVKEF IIKISPIILN TVLTIMAALS PKTKEDGSKD TSKEMENLWG IKSINDYNTW FLGVDTATEI TESFKGIEHS LIEENCGVVV ESIQVTLECG LGHRTVPLLL AESKFSGNIK NWTSLMAAVA DVTLQVHYYN EIHAVWEPLI ERVEGKRQWN LRLDVKKNPV QDKSLLPGDD FIPEPQMAIH ISSGNTMNIT ISKSCLNVFN NLAKGFSEGT ASTFDYSLKD RAPFTVKNAV GVPIKVKPNC NLRVMGFPEK SDIFDVDAGQ NLELEYASMV PSSQGNLSIL SRQESSFFTL TIVPHGYTEV ANIPVARPGR RLYNVRNPNA SHSDSVLVQI DATEGNKVIT LRSPLQIKNH FSIAFIIYKF VKNVKLLERI GIARPEEEFH VPLDSYRCQL FIQPAGILEH QYKESTTYIS WKEELHRSRE VRCMLQCPSV EVSFLPLIVN TVALPDELSY ICTHGEDWDV AYIIHLYPSL TLRNLLPYSL RYLLEGTAET HELAEGSTAD VLHSRISGEI MELVLVKYQG KNWNGHFRIR DTLPEFFPVC FSSDSTEVTT VDLSVHVRRI GSRMVLSVFS PYWLINKTTR VLQYRSEDIH VKHPADFRDI ILFSFKKKNI FTKNKVQLKI STSAWSSSFS LDTVGSYGCV KCPANNMEYL VGVSIKMSSF NLSRIVTLTP FCTIANKSSL ELEVGEIASD GSMPTNKWNY IASSECLPFW PESLSGKLCV RVVGCEGSSK PFFYNRQDNG TLLSLEDLNG GILVDVNTAE HSTVITFSDY HEGSAPALIM NHTPWDILTY KQSGSPEEMV LLPRQARLFA WADPTGTRKL TWTYAANVGE HDLLKDGCGQ FPYDANIQIH WVSFLDGRQR VLLFTDDVAL VSKALQAEEM EQADYEITLS LHSLGLSLVN NESKQEVSYI GITSSGVVWE VKPKQKWKPF SQKQIILLEQ SYQKHQISRD HGWIKLDNNF EVNFDKDPME MRLPIRSPIK RDFLSGIQIE FKQSSHQRSL RARLYWLQVD NQLPGAMFPV VFHPVAPPKS IALDSEPKPF IDVSVITRFN EYSKVLQFKY FMVLIQEMAL KIDQGFLGAI IALFTPTTDP EAERRRTKLI QQDIDALNAE LMETSMTDMS ILSFFEHFHI SPVKLHLSLS LGSGGEESDK EKQEMFAVHS VNLLLKSIGA TLTDVDDLIF KLAYYEIRYQ FYKRDQLIWS VVRHYSEQFL KQMYVLVLGL DVLGNPFGLI RGLSEGVEAL FYEPFQGAVQ GPEEFAEGLV IGVRSLFGHT VGGAAGVVSR ITGSVGKGLA AITMDKEYQQ KRREELSRQP RDFGDSLARG GKGFLRGVVG GVTGIITKPV EGAKKEGAAG FFKGIGKGLV GAVARPTGGI VDMASSTFQG IQRAAESTEE VSSLRPPRLI HEDGIIRPYD RQESEGSDLL ENHIKKLEGE TYRYHCAIPG SKKTILMVTN RRVLCIKEVE ILGLMCVDWQ CPFEDFVFPP SVSENVLKIS VKEQGLFHKK DSANQGCVRK VYLKDTATAE RACNAIEDAQ STRQQQKLMK QSSVRLLRPQ LPS